Shares of Cerner Co. (NASDAQ:CERN) have earned an average recommendation of “Buy” from the eighteen research firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $74.73.
A number of analysts have weighed in on CERN shares. Argus raised Cerner from a “hold” rating to a “buy” rating in a research report on Thursday, August 22nd. Jefferies Financial Group lowered Cerner from a “buy” rating to a “hold” rating and increased their price target for the stock from $69.00 to $75.00 in a research report on Friday, August 23rd. Citigroup increased their price target on Cerner from $77.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, July 25th. ValuEngine lowered Cerner from a “buy” rating to a “hold” rating in a research report on Wednesday, September 4th. Finally, KeyCorp reaffirmed an “overweight” rating and set a $82.00 price objective (up previously from $76.00) on shares of Cerner in a report on Friday, August 16th.
Shares of NASDAQ CERN traded up $0.16 during mid-day trading on Friday, hitting $67.84. The company had a trading volume of 695,317 shares, compared to its average volume of 1,672,493. The stock has a market cap of $21.70 billion, a price-to-earnings ratio of 30.70, a PEG ratio of 1.92 and a beta of 0.92. Cerner has a 12 month low of $48.78 and a 12 month high of $76.47. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.52 and a quick ratio of 2.50. The firm’s 50 day simple moving average is $69.37 and its two-hundred day simple moving average is $67.40.
Cerner (NASDAQ:CERN) last announced its earnings results on Wednesday, July 24th. The company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.58 by $0.02. Cerner had a return on equity of 15.14% and a net margin of 10.75%. The firm had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the previous year, the business earned $0.62 EPS. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. Equities analysts forecast that Cerner will post 2.43 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 9th. Shareholders of record on Wednesday, September 25th will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 1.06%. The ex-dividend date of this dividend is Tuesday, September 24th. Cerner’s dividend payout ratio is 32.58%.
In other Cerner news, VP Donald Trigg sold 29,423 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $67.72, for a total transaction of $1,992,525.56. Following the completion of the transaction, the vice president now owns 256,354 shares in the company, valued at approximately $17,360,292.88. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Julie L. Gerberding sold 7,928 shares of the stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $71.82, for a total value of $569,388.96. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 344,268 shares of company stock worth $23,243,010. Company insiders own 0.75% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in the business. Nelson Roberts Investment Advisors LLC acquired a new stake in shares of Cerner in the first quarter valued at approximately $25,000. Berman Capital Advisors LLC grew its position in shares of Cerner by 115.3% in the 2nd quarter. Berman Capital Advisors LLC now owns 381 shares of the company’s stock worth $27,000 after acquiring an additional 204 shares in the last quarter. Advisory Alpha LLC acquired a new position in shares of Cerner in the 1st quarter worth approximately $28,000. Altshuler Shaham Ltd grew its position in shares of Cerner by 173.2% in the 2nd quarter. Altshuler Shaham Ltd now owns 388 shares of the company’s stock worth $28,000 after acquiring an additional 246 shares in the last quarter. Finally, CSat Investment Advisory L.P. lifted its holdings in shares of Cerner by 119.7% in the 2nd quarter. CSat Investment Advisory L.P. now owns 637 shares of the company’s stock worth $47,000 after purchasing an additional 347 shares during the last quarter. Hedge funds and other institutional investors own 82.66% of the company’s stock.
Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Further Reading: What is the G-20?
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.